Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et al
S Banerjee, M Preusser, J Tabernero, et al.
Neuropathology and Applied Neurobiology
|
June 4, 2004
Ten years of EC-funded concerted actions on the neuropathology of prion disease: report on the final scientific meeting (31 October-2 November 2003, Baden near Vienna, Austria)
M Preusser, E Gelpi, J A Hainfellner, et al.
ESMO Open
|
February 2, 2023
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
B Fendl, A S Berghoff, M Preusser, et al.
Histopathology
|
January 30, 2007
OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms
M Preusser, H Budka, K Rössler, et al.
Histopathology
|
June 5, 2007
Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker
U Laggner, I Pipp, H Budka, et al.
Neuropathology and Applied Neurobiology
|
January 24, 2007
Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies
B Sikorska, W Papierz, M Preusser, et al.
Neuropathology and Applied Neurobiology
|
October 27, 2007
Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease
J Attems, M Preusser, M Grosinger-Quass, et al.
ESMO Open
|
May 17, 2023
Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort
M J Mair, M Mitterer, T Buratti, et al.
Histopathology
|
February 21, 2006
Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology
M Preusser, U Laggner, C Haberler, et al.
The British Journal of Dermatology
|
November 29, 2015
Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo
P Tschandl, A S Berghoff, M Preusser, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et al
S Banerjee, M Preusser, J Tabernero, et al.
Neuropathology and Applied Neurobiology
|
June 4, 2004
Ten years of EC-funded concerted actions on the neuropathology of prion disease: report on the final scientific meeting (31 October-2 November 2003, Baden near Vienna, Austria)
M Preusser, E Gelpi, J A Hainfellner, et al.
ESMO Open
|
February 2, 2023
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
B Fendl, A S Berghoff, M Preusser, et al.
Histopathology
|
January 30, 2007
OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms
M Preusser, H Budka, K Rössler, et al.
Histopathology
|
June 5, 2007
Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker
U Laggner, I Pipp, H Budka, et al.
Neuropathology and Applied Neurobiology
|
January 24, 2007
Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies
B Sikorska, W Papierz, M Preusser, et al.
Neuropathology and Applied Neurobiology
|
October 27, 2007
Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease
J Attems, M Preusser, M Grosinger-Quass, et al.
ESMO Open
|
May 17, 2023
Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort
M J Mair, M Mitterer, T Buratti, et al.
Histopathology
|
February 21, 2006
Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology
M Preusser, U Laggner, C Haberler, et al.
The British Journal of Dermatology
|
November 29, 2015
Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo
P Tschandl, A S Berghoff, M Preusser, et al.
Page
of 7